Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01575470 · ClinicalTrials.gov registry record · Phase 1
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT01575470: Completed Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
NCT01575470 is a Phase 1 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 25 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01575470, a Phase 1 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if bone marrow harvest, BMMNC separation, and re-infusion in adults with acute severe TBI is safe and will improve functional outcome. 12/09/2015 Update: The study is closed to new enrollment and all follow-up visits have been completed. Data analysis is underway.
Interventions
- BIOLOGICAL autologous bone marrow mononuclear cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-05 |
| Phase | Phase 1 |
What the finished NCT01575470 record still lists
NCT01575470 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 1 intervention - of which autologous bone marrow mononuclear cells is the first listed.
NCT01575470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01575470 about?
NCT01575470 is a clinical study titled "Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells". The purpose of this study is to determine if bone marrow harvest, BMMNC separation, and re-infusion in adults with acute severe TBI is safe and will improve functional outcome. 12/09/2015 Update: The study is closed to new enrollment and all follow-up visits have been completed. Data analysis is un...
What is the current status of trial NCT01575470?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2012-03. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01575470?
The interventions under investigation include: autologous bone marrow mononuclear cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT01575470?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01575470's enrollment target sits among peer trials
25 1495th of 2000 higher than 481 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia